What I will say is that the metabolic profile patients end up with after 12 weeks (better fasting glucose, lower A1c, better lipids, more lean mass relative to fat) maps closely to what longevity researchers consider markers of healthy aging
Biomark Res
These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers
By documenting your peptide-pathway genetic profile, your provider can submit a more compelling medical necessity argument that addresses insurance company concerns about treatment appropriateness
It typically occurs later in life (usually after age 50) though it may start earlier, especially if your joints have become damaged by rheumatoid arthritis or injury
It controls appetite and slows digestion, helping you feel full longer, which reduces food intake and supports weight loss
